LIVONIA, Mich., Jan. 10, 2024 /PRNewswire/ — The recent outbreak of a mysterious respiratory illness among dogs in the United States has caused concern among pet owners and veterinary experts. With cases reported in over 16 states, including California, Florida, and Massachusetts, there is a growing need for solutions to keep dogs safe. That’s where … Read more
TOKYO, Jan. 8, 2024 /PRNewswire/ — Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, “Astellas”) today announced the U.S. Food and Drug Administration (FDA) issued a complete response letter on January 4, 2024, regarding the Biologics License Application (BLA) for zolbetuximab, an investigational agent for the treatment of patients with locally advanced unresectable … Read more
SINGAPORE, Jan. 7, 2024 /PRNewswire/ — Juniper Biologics (“Juniper“), a global science-led pharmaceutical company headquartered in Singapore, proudly announces its latest achievement, winning the award for Molecular Science & Technology Acquisition of the Year at Acquisition International’s M&A Awards 2023. This recognition highlights Juniper’s unwavering commitment to advancing treatments in oncology-supportive care and its overarching mission … Read more
MILWAUKEE, Jan. 6, 2024 /PRNewswire/ — As the pursuit of education becomes increasingly vital in shaping the future of healthcare, the esteemed Dr. Scott Kamelle announces the launch of the Dr. Scott Kamelle Grant for Healthcare Students. This groundbreaking scholarship aims to support and nurture the brightest minds in healthcare education, propelling them toward their aspirations … Read more
Strong revenue generation in Q4 2023, including SEK 43m in Idefirix® product sales supported by growth in new markets such as U.K., Germany, and Spain Encouraging first results from first-in-human trial of HNSA-5487, Hansa’s lead candidate from the NiceR program for repeat dosing Initiation of phase 1b trial of imlifidase as pre-treatment to Sarepta’s SRP-9001 in DMD … Read more
DUBAI, UAE, Jan. 3, 2024 /PRNewswire/ — As per the recent report released by Kings Research, the global Digital Genome Market revenue was recorded at USD 22.22 billion in 2022 and is likely to reach USD 92.93 billion by 2030, growing at a 19.58% CAGR from 2023 to 2030. Numerous pivotal factors fueling the market … Read more
PEQUIM, 2 de janeiro de 2024 /PRNewswire/ — O Índice de Preços do Cordyceps Sinensis Silvestre da Xinhua-Yushu foi divulgado oficialmente em 27 de dezembro em Pequim, capital da China, indicando o desenvolvimento acelerado do setor de cordyceps sinensis silvestre rumo a uma nova etapa do modo digital, informativo e moderno. A foto mostra a cerimônia … Read more
Behavioral health expert breaks down five steps to a New Year You MEMPHIS, Tenn., Jan. 1, 2024 /PRNewswire/ — It’s that time of year. A new year is rushing in, and many people take time to set resolutions for self-improvement. Often, those resolutions are centered on losing weight or living a healthier life. How can … Read more
The series was based on the recent Stanford Study that showed multiple benefits of eating plant-based after just four weeks of the diet change. The participants with a plant-based diet had significantly less body weight and insulin — all of which are associated with improved cardiovascular health — than the meat-eating participants. “You Are What … Read more
Latest offer to WellNow is lower than a decade ago SYRACUSE, N.Y., Dec. 29, 2023 /PRNewswire/ — The latest offer from Excellus BlueCross BlueShield to Upstate New York’s largest urgent care services provider is less than it paid ten years ago while over the same time period has convinced New York State to raise its prices … Read more